Target Group Inc. (CBDY) stock
CBDYOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $431.92KP/E –Yield –
Target r&d expenses
Research and development expenses are spending on new products and technology.
Target's R&D Expenses for the twelve months ending Dec 31, 2018 was $91.85K. For fiscal 2018 it was $91.85K, up 5.2% from the year before. The highest annual figure on record is $114.04K in fiscal 2016.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $91.85K | +5.2% |
| FY2017 | Dec 31, 2017 | $87.31K | -23.4% |
| FY2016 | Dec 31, 2016 | $114.04K | +264.1% |
| FY2015 | Dec 31, 2015 | $31.32K | – |
| FY2014 | Dec 31, 2014 | $0 | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018 | Dec 31, 2018 | $57.51K | +56.8% |
| Q3 FY2018 | Sep 30, 2018 | $11.75K | -51.7% |
| Q2 FY2018 | Jun 30, 2018 | $12.36K | -66.4% |
| Q1 FY2018 | Mar 31, 2018 | $10.24K | -71.3% |
| Q2 FY2017 | Jun 30, 2017 | $36.68K | +1967.8% |
| Q1 FY2017 | Mar 31, 2017 | $24.32K | – |
| Q4 FY2016 | Dec 31, 2016 | $36.73K | – |
| Q3 FY2016 | Sep 30, 2016 | $35.65K | – |
| Q4 FY2015 | Dec 31, 2015 | $1.77K | – |
See a number that looks wrong?